Alkaptonuria
Rare genetic disorder causing dark urine and joint damage.
Alkaptonuria is a rare inherited genetic disease caused by a mutation in the HGD gene for the enzyme homogentisate 1,2-dioxygenase. It is a recessive condition, meaning a person must inherit an abnormal copy from both parents, leading to accumulation of homogentisic acid in the blood and tissues. This accumulation causes damage to cartilage, heart valves, and can precipitate as stones in various organs, with symptoms typically developing after age 30.
- prevalence
- 1 in 250,000 people overall; 1 in 19,000 in Slovakia; elevated in the Dominican Republic (approximately 1 in 70,000 to 1 in 100,000)
- inheritance
- Autosomal recessive
Lore & Background
Alkaptonuria was one of the four diseases described by Archibald Edward Garrod as resulting from metabolic deficiencies. He linked ochronosis with alkaptan accumulation in 1902, and his views on inheritance were summarized in a 1908 Croonian Lecture. The genetics were also studied by William Bateson in 1902. The specific enzyme defect was identified in a 1958 study, and the genetic basis was elucidated in 1996 when HGD mutations were demonstrated. A 1977 study suggested an Egyptian mummy had suffered from alkaptonuria.
Reader's Guide
Alkaptonuria is significant as one of the first diseases recognized as an inborn error of metabolism, establishing the concept that genetic defects can cause accumulation of intermediates. Its study has advanced understanding of enzyme deficiencies and autosomal recessive inheritance. The development of nitisinone as a treatment, approved in Europe in 2020, represents a successful repurposing of a drug originally for hereditary tyrosinaemia type-1. Nitisinone lowers homogentisic acid levels by 99%, halting disease progression, though it requires careful monitoring for hypertyrosinaemia. The disease's higher prevalence in Slovakia and the Dominican Republic highlights founder effects and genetic clustering. Despite not affecting life expectancy, alkaptonuria severely impacts quality of life through pain, joint replacement needs, and cardiac complications.
Did You Know?
- Urine from people with alkaptonuria turns brown or inky black when exposed to open air.
- The disease is more common in Slovakia, with a prevalence of 1 in 19,000, and also elevated in the Dominican Republic.
- Nitisinone lowers homogentisic acid levels by 99% and was approved for treatment in Europe in 2020.
- Hearing loss is a known complication of alkaptonuria, though the exact percentage varies among studies.
More in Rare diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record